Immunotherapy-Induced Acute Gastritis: First Case Report of Nivolumab Re-Challenge after Severe Immune-Mediated Inflammatory Response. acmcr. 2022;6(2):182-188. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22594